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ABSTRACT
The objective of this study was to investigate the incidence of familial carpal tunnel syndrome in patients admitted to the 
authors’ institution for carpal tunnel release. Questionnaires completed by 120 patients: 92 women (77%) and 28 men (23%) at 
a mean age of 56 years at their baseline clinical examination were reviewed. Familial occurrence of the disease was noted in 21 
patients (17%): 16 women and five men. Three family members were affected in three patients, two relatives in eight patients, 
and one relative in 10 patients, giving a total of 35 affected relatives. The patients’ sisters (n = 16) were the most commonly 
involved, followed by mothers (n = 12), daughters (n = 2), brothers (n = 2), grandmothers (n = 2) and an aunt (n = 1). Bilateral 
manifestation of the disease was noted in 19 patients (90%) and in 31 (88%) of their affected relatives. The results suggest that 
carpal tunnel syndrome shows a moderate tendency to familial occurrence and, if so, it usually manifests bilaterally.
Key words: carpal tunnel syndrome, inheritable traits, familial predispositions, bilateral presentation 
(Neurol Neurochir Pol 2019; 53 (1): 43–46)
Introduction
Controversy has been considerable regarding the incidence 
of familial occurrence of carpal tunnel syndrome (CTS). 
Individual families have been reported where most of the 
members have been affected, and the results of some popu-
lation-based studies have shown a higher incidence of the 
condition among relatives of some patients. The first report 
of the occurrence of CTS among members of the same family 
was made in 1959 [1]. A decade later, Phalen noticed that 
a proportion of his CTS patients had declared occurrence 
of the same symptoms in their family members, suggesting 
familial predisposition to the syndrome [2]. These findings 
were confirmed by Radecki, who showed that 165 of 421 pa-
tients (39%) operated on for CTS had relatives suffering from 
the same symptoms in their hands [3]. The author suggests 
that inheritable carpal tunnel syndrome may be caused by 
biochemical, developmental or anatomical changes of the 
carpal tunnel. In contrast, on the basis of literature reviews, 
other authors have found that true inheritable carpal tunnel 
syndrome occurs very rarely [4]. 
The objective of this study was to investigate the incidence 
of familial carpal tunnel syndrome in patients admitted to the 
authors’ institution for carpal tunnel release. 
Materials and methods
Questionnaires completed at baseline clinical examination 
by 120 patients with CTS admitted to the authors’ institution 
between December 2017 and March 2018 (a period of four 
months) were reviewed. The approval of the Bioethical Coun-
cil of the local Medical University was obtained for funding 
the Carpal Tunnel Syndrome Register and for performance 
of further analyses. Informed consent was obtained from all 
subjects before enrolment. There were 92 women (77%) and 
28 men (23%) with a mean age of 56 years (range 33–84). 
The diagnosis of CTS was made on the basis of clinical and 
electrophysiological grounds. In all of these patients, nerve 
conduction studies were positive, confirming the diagnosis. 
The following grading scale of the severity of electrophysio-
logical abnormalities was used in our study: 
Grade I (mild). Decreased sensory nerve conduction 
(< 40 m/s) and SNAP recordable with normal (≥ 10 µV) 
or decreased (1–9 µV) amplitude. DML normal or slightly 
prolonged (3.5–4.0 ms). CMAP normal (≥ 4 mV). Normal 
EMG recording from APB. 
Grade II (moderate). SNAP non-recordable. DML pro-
longed > 4 ms. CMAP normal or decreased (2–4 mV). Normal 
or moderately neurogenic EMG recording from APB. 
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Table 1. Demographic and clinical data obtained from patients with familial carpal tunnel syndrome
ID Sex Age Duration 
of CTS
Affected relatives Time of onset of CTS 
in relatives
Hand involved Comorbidities Treatment
1 F 67 20 y 2 sisters 10 and 20 years ago Bilateral No Not operated
2 F 78 1 y 2 daughters 2 and 4 years ago Bilateral No 1 operated
3 M 55 2 y Mother 15 years ago Bilateral Diabetes Not operated
4 F 69 10 y 2 sisters 19 years ago Bilateral No 1 operated
5 M 56 10 y Sister 5 years ago Left Thyroidectomy Not operated
6 F 35 1 y Mother and aunt 18 and 7 years ago Bilateral No Not operated
7 F 51 5 y Sister 7 years ago Bilateral No Operated
8 F 55 5 y Mother 10 years ago Bilateral No Operated
9 F 49 10 y Sister 9 years ago Bilateral No Operated
10 F 45 8 y Mother 15 years ago Right No Not operated
11 M 65 2 y 2 brothers and sister 4 years ago Bilateral No Not operated
12 M 51 7 y Mother, sister 15 and 10 years ago Bilateral No Operated
13 F 59 1 y Sister 3 years ago Right No Not operated
14 F 57 2 y Mother, sister 3 and 2 years ago Bilateral No Not operated
15 F 51 2 y Grandmother 30 years ago Bilateral No Operated
16 F 33 1 y Grandmother, mother, 
sister
3-30 years ago Bilateral No 1 operated
17 M 51 7 y Mother, sister 15 and 10 years ago Bilateral No Operated
18 F 59 1 y Sister 3 years ago Right No Not operated
19 F 57 2 y Mother, sister 3 and 2 years ago Bilateral Diabetes Not operated
20 F 51 2 y Mother 30 years ago Bilateral No Operated 
21 F 33 1 y Grandmother, mother, 
sister
5-30 years ago Bilateral No 1 operated
Grade III (severe). SNAP non-recordable. DML prolonged 
> 4 ms. CMAP decreased < 2 mV) or non-recordable. EMG 
showing massive or complete muscle denervation.
Basic demographic and clinical information was recor-
ded in the questionnaire (Tab. 1). All participants were then 
asked whether they knew of any family members with carpal 
tunnel syndrome. In the event of a positive answer, patients 
were asked to indicate which of their relatives was affected, 
when the disease was diagnosed, which hand was involved, 
and how they were treated. All information was self-reported. 
If a given patient knew about a family member who suffered 
from CTS, but was unable to provide the required details (did 
not recall), this case was not considered as ‘familial CTS’. The 
presence of comorbidities potentially predisposed to CTS was 
also recorded [6].
Results
Familial occurrence of the disease was noted in 21 patients 
(17%): 16 women and five men. Three family members were 
affected in three patients, two relatives in eight patients, 
and one relative in 10 patients, giving a total of 35 affected 
relatives. Patients’ sisters (n = 16) were the most commonly 
affected, followed by mothers (n = 12), daughters (n = 2), 
brothers (n = 2), grandmothers (n = 2) and an aunt (n = 1). 
Bilateral manifestation of the disease was noted in 19 of 21 
patients (90%) and in 31 of 35 (88%) of their affected relatives. 
The disease in patients’ family members was diagnosed  2-30 
years earlier than in the patients themselves. Thirteen of 35 
relatives (37%) were operated on. Three patients (14%) had 
comorbidities potentially predisposed to CTS: two had diabe-
tes and one underwent thyroidectomy. No systemic disease, 
neuropathy, history of wrist trauma, or drug use was noted 
in other patients.  
Discussion
The results of this study show a fairly common (17%) incidence 
of CTS among relatives of patients. This is significantly higher 
than in the general population (1%) and in women > 40 years 
old (5%) [5]. This result does not automatically confirm the 
hypothesis of inheritability of the syndrome in some fami-
lies. There are many factors predisposing to CTS, such as 
constitutional traits (short height, thicksetness and obesity), 
diseases (diabetes, hypothyroidism, rheumatoid arthritis) or 
developmental and anatomical changes of the carpal tunnel 
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(4–8). Only some of them can be suspected of inheritability, 
but none were identified in our patients. Nevertheless, the 
occurrence of the syndrome in several members of one family 
may suggest that the risk of hereditary factors being present 
is higher than in the general population. 
Several hereditary biochemical disorders have been 
identified predisposing to carpal tunnel syndrome, such as 
inheritable myopathies, familial hypercholesterolemia, familial 
amyloidosis, or hereditary neuropathy with liability to pressure 
palsies [9–11]. The incidence of CTS in families affected by 
these diseases is much higher than in the general population, 
and onset of the syndrome occurs early, usually in the second 
or third decade of life. Inheritable structural variations in the 
size of the tunnel or the volume of its contents have also been 
reported as predisposing to familial occurrence of the syndro-
me [12–14]. The results of our study also showed a significantly 
higher incidence of bilateral disease in patients with familial 
CTS: it occurred in 18 of 21 patients and in 31 of 35 their re-
latives. This finding was similar to that reported in a study by 
Alford et al.: 45% of patients with bilateral syndrome declared 
occurrence of the same symptoms in their family members, 
compared to 27% of patients with unilateral CTS declaring 
the same. The authors suggested the presence of inheritability 
of variations in the size of the carpal tunnel or its contents, 
which would manifest themselves bilaterally and may cause 
a predisposition for developing the syndrome [7].
The direct causes of idiopathic carpal tunnel syndrome 
remain obscure. Three different mechanisms are suspected 
to be involved in genetic predisposition to carpal tunnel 
syndrome: collagen synthesis, collagen degradation, and 
protection against oxidative stress effect in connective tissue. 
Several gene groups are involved in the regulation and mo-
dulation of these mechanisms, and results from the presented 
studies have shown their possible effect on the development 
of carpal tunnel syndrome. Variants within the COL1A1, 
COL5A1 and COL11A1 genes encoding synthesis of minor 
collagen subtypes may be potentially involved, as they alter 
the mechanical properties of tendons and other connective 
tissue structures within the carpal tunnel [15]. The collagen 
within connective tissue structures is also remodelled by ma-
trix metalloproteinases (MMPs) and variants of these genes 
have also been investigated for their possible role in the risk of 
CTS development [16]. Next, the variants of genes encoding 
glutathione S-transferase synthesis were found to be involved 
in CTS aetiology [17]. These mechanisms may play a potential 
role as genetic risk factors in carpal tunnel syndrome and in 
its familial occurrence. 
Self-reporting of the data placed unavoidable limitations 
on the accuracy of our data because we relied on patients’ 
awareness of their family members’ conditions. One may 
suspect that some of them, particularly in older age, might 
simply forget the presence of the disease in their relatives. In 
some families, their members live far away from each other 
and contact each other infrequently. We were not able to assess 
the degree to which our patients were underreporting family 
members with carpal tunnel syndrome of whom they were 
unaware. For this reason, the incidence of familial CTS in our 
material could be underestimated, in which case it emphasises 
still more the existence of the problem.  
Clinical implications and future directions
The results of our study show that carpal tunnel syndrome 
has a moderate tendency to familial occurrence and that most 
familial cases occur in patients with bilateral disease. These 
findings seem not to have a direct translation into clinical 
practice, but may indicate the need for further investigations 
of this field. We believe that a question about family history 
should be added to the routine examination of each patient 
diagnosed with carpal tunnel syndrome.
References
1. TANZER RC. The carpal-tunnel syndrome; a clinical and anatomical 
study. J Bone Joint Surg Am. 1959; 41-A(4): 626–634, indexed in 
Pubmed: 13664702.
2. Phalen GS. Reflections on 21 years’ experience with the carpal-tunnel 
syndrome. JAMA. 1970; 212(8): 1365–1367, indexed in Pubmed: 
5467525.
3. Radecki P. The familial occurrence of carpal tunnel syndrome. Muscle 
Nerve. 1994; 17(3): 325–330, doi: 10.1002/mus.880170311, inde-
xed in Pubmed: 8107710.
4. Gossett JG, Chance PF. Is there a familial carpal tunnel syndrome? 
An evaluation and literature review. Muscle Nerve. 1998; 21(11): 
1533–1536, indexed in Pubmed: 9771681.
5. Atroshi I, Gummesson C, Ornstein E, et al. Prevalence of carpal tunnel 
syndrome in a general population. JAMA. 1999; 282(2): 153–158, 
indexed in Pubmed: 10411196.
6. Padua L, Coraci D, Erra C, et al. Carpal tunnel syndrome: clinical 
features, diagnosis, and management. Lancet Neurol. 2016; 15(12): 
1273–1284, doi: 10.1016/S1474-4422(16)30231-9, indexed in 
Pubmed: 27751557.
7. Alford JW, Weiss APC, Akelman E. The familial incidence of carpal 
tunnel syndrome in patients with unilateral and bilateral disease. 
Am J Orthop (Belle Mead NJ). 2004; 33(8): 397–400, indexed in 
Pubmed: 15379235.
8. Żyluk A, Dąbal L, Szlosser Z. Constitutional factors and predispo-
sition to carpal tunnel syndrome. Pol Orthop Traumatol. 2011; 76: 
127–132.
9. Leifer D, Cros D, Halperin JJ, et al. Familial bilateral carpal tunnel 
syndrome: report of two families. Arch Phys Med Rehabil. 1992; 73(4): 
393–397, indexed in Pubmed: 1554316.
10. Murakami T, Tachibana S, Endo Y, et al. Familial carpal tunnel syn-
drome due to amyloidogenic transthyretin His 114 variant. Neurology. 
1994; 44(2): 315–318, indexed in Pubmed: 8309582.
11. Ihara Y, Nobukuni K, Namba R, et al. A family of familial hypercho-
lesterolemia with cerebral infarction and without coronary heart 
disease. An unusual case with corneal opacity, polyneuropathy and 
carpal tunnel syndrome in the family: therapy with probucol and 
tocopherol nicotinate. J Neurol Sci. 1991; 106(1): 10–18, indexed in 
Pubmed: 1779233.
46
Neurologia i Neurochirurgia Polska 2019, vol. 53, no. 1
www.journals.viamedica.pl/neurologia_neurochirurgia_polska
12. Michaud LJ, Hays RM, Dudgeon BJ, et al. Congenital carpal tunnel syn-
drome: case report of autosomal dominant inheritance and review of 
the literature. Arch Phys Med Rehabil. 1990; 71(6): 430–432, indexed 
in Pubmed: 2185719.
13. Iannicelli E, Chianta GA, Salvini V, et al. Evaluation of bifid median 
nerve with sonography and MR imaging. J Ultrasound Med. 2000; 
19(7): 481–485, indexed in Pubmed: 10898302.
14. Mahjneh I, Saarinen A, Siivola J. Familial carpal tunnel syndrome: a re-
port of a Finnish family. Acta Neurol Scand. 2001; 104(6): 377–379, 
indexed in Pubmed: 11903093.
15. Dada S, Burger MC, Massij F, et al. Carpal tunnel syndrome: The role of 
collagen gene variants. Gene. 2016; 587(1): 53–58, doi: 10.1016/j.
gene.2016.04.030, indexed in Pubmed: 27090000.
16. Burger MC, De Wet H, Collins M. Matrix metalloproteinase genes on 
chromosome 11q22 and risk of carpal tunnel syndrome. Rheumatol 
Int. 2016; 36(3): 413–419, doi: 10.1007/s00296-015-3385-z, inde-
xed in Pubmed: 26521080.
17. Kim JK, Koh YDo, Kim JS, et al. Oxidative stress in subsynovial con-
nective tissue of idiopathic carpal tunnel syndrome. J Orthop Res. 
2010; 28(11): 1463–1468, doi: 10.1002/jor.21163, indexed in 
Pubmed: 20872582.
